These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 11248405)
1. Design, synthesis and binding properties of novel and selective 5-HT(3) and 5-HT(4) receptor ligands. Modica M; Santagati M; Guccione S; Russo F; Cagnotto A; Goegan M; Mennini T Eur J Med Chem; 2000 Dec; 35(12):1065-79. PubMed ID: 11248405 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and binding properties of novel and selective 5-HT3 and 5-HT4 receptor ligands. Modica M; Santagati M; Guccione S; Russo F; Cagnotto A; Goegan M; Mennini T Eur J Med Chem; 2001 Mar; 36(3):287-301. PubMed ID: 11337106 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and binding properties of novel selective 5-HT3 receptor ligands. Modica M; Romeo G; Materia L; Russo F; Cagnotto A; Mennini T; Gáspár R; Falkay G; Fülöp F Bioorg Med Chem; 2004 Jul; 12(14):3891-901. PubMed ID: 15210156 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and receptor binding of new thieno[2,3-d]-pyrimidines as selective ligands of 5-HT(3) receptors. Modica MN; Romeo G; Salerno L; Pittalà V; Siracusa MA; Mereghetti I; Cagnotto A; Mennini T; Gáspár R; Gál A; Falkay G; Palkó M; Maksay G; Fülöp F Arch Pharm (Weinheim); 2008 Jun; 341(6):333-43. PubMed ID: 18535994 [TBL] [Abstract][Full Text] [Related]
5. Novel potent 5-HT(3) receptor ligands based on the pyrrolidone structure: synthesis, biological evaluation, and computational rationalization of the ligand-receptor interaction modalities. Cappelli A; Anzini M; Vomero S; Mennuni L; Makovec F; Doucet E; Hamon M; Menziani MC; De Benedetti PG; Giorgi G; Ghelardini C; Collina S Bioorg Med Chem; 2002 Mar; 10(3):779-801. PubMed ID: 11814868 [TBL] [Abstract][Full Text] [Related]
6. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives. Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096 [TBL] [Abstract][Full Text] [Related]
7. High affinity and selectivity of [[(arylpiperazinyl)alkyl]thio]thieno[2,3-d]pyrimidinone derivatives for the 5-HT(1A) receptor. Synthesis and structure-affinity relationships. Modica M; Santagati M; Russo F; Selvaggini C; Cagnotto A; Mennini T Eur J Med Chem; 2000; 35(7-8):677-89. PubMed ID: 10960183 [TBL] [Abstract][Full Text] [Related]
8. New pyridobenzodiazepine derivatives: modifications of the basic side chain differentially modulate binding to dopamine (D(4.2), D(2L)) and serotonin (5-HT(2A)) receptors. Liégeois JF; Eyrolles L; Ellenbroek BA; Lejeune C; Carato P; Bruhwyler J; Géczy J; Damas J; Delarge J J Med Chem; 2002 Nov; 45(23):5136-49. PubMed ID: 12408724 [TBL] [Abstract][Full Text] [Related]
9. Conformationally constrained butyrophenones with mixed dopaminergic (D(2)) and serotoninergic (5-HT(2A), 5-HT(2C)) affinities: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and -thienocycloalkanones as putative atypical antipsychotics. Raviña E; Negreira J; Cid J; Masaguer CF; Rosa E; Rivas ME; Fontenla JA; Loza MI; Tristán H; Cadavid MI; Sanz F; Lozoya E; Carotti A; Carrieri A J Med Chem; 1999 Jul; 42(15):2774-97. PubMed ID: 10425088 [TBL] [Abstract][Full Text] [Related]
10. Quinolizidinyl derivatives of 2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxylic acid and 1-homolupinanoyl benzimidazolones as ligands for 5-HT3 and 5-HT4 receptors. Sparatore A; Cagnotto A; Sparatore F Farmaco; 1999 Apr; 54(4):248-54. PubMed ID: 10384719 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and preliminary pharmacological results on new naphthalene derivatives as 5-HT(4) receptor ligands. Diouf O; Depreux P; Chavatte P; Poupaert JH Eur J Med Chem; 2000; 35(7-8):699-706. PubMed ID: 10960185 [TBL] [Abstract][Full Text] [Related]
12. New esters of 4-amino-5-chloro-2-methoxybenzoic acid as potent agonists and antagonists for 5-HT4 receptors. Yang D; Soulier JL; Sicsic S; Mathé-Allainmat M; Brémont B; Croci T; Cardamone R; Aureggi G; Langlois M J Med Chem; 1997 Feb; 40(4):608-21. PubMed ID: 9046352 [TBL] [Abstract][Full Text] [Related]
13. Identification of a series of benzoxazoles as potent 5-HT6 ligands. Liu KG; Lo JR; Comery TA; Zhang GM; Zhang JY; Kowal DM; Smith DL; Di L; Kerns EH; Schechter LE; Robichaud AJ Bioorg Med Chem Lett; 2009 Feb; 19(4):1115-7. PubMed ID: 19152787 [TBL] [Abstract][Full Text] [Related]
15. Benzimidazole derivatives. Part 1: Synthesis and structure-activity relationships of new benzimidazole-4-carboxamides and carboxylates as potent and selective 5-HT4 receptor antagonists. López-Rodríguez ML; Benhamú B; Viso A; Morcillo MJ; Murcia M; Orensanz L; Alfaro MJ; Martín MI Bioorg Med Chem; 1999 Nov; 7(11):2271-81. PubMed ID: 10632037 [TBL] [Abstract][Full Text] [Related]